Ravikiran Vedururu, PhD, MBA, has been appointed as Chief Scientific Officer at Vigilare. With over 17 years of international experience across biotechnology, genomics, clinical diagnostics, and scientific leadership, he will lead the company’s scientific strategy, regulatory initiatives, and global client engagements while supporting innovation across life sciences and healthcare.
Prior to joining Vigilare, Ravi Co-Founded Fragment BioTech and previously served as Scientific Lead- Genomics (Principal Scientist) at Monash Health. Earlier, he held leadership positions as Head of Operations and R&D at Pandorum Technologies and Developmental Medical Scientist at Peter MacCallum Cancer Centre. He completed his PhD at CSIRO’s Australian Centre for Disease Preparedness.
Alongside his PhD, Ravi holds a Global Executive MBA from Monash Business School, combining scientific expertise with strategic business leadership. At Vigilare, he will drive scientific excellence, strengthen regulatory and pharmacovigilance capabilities, and support global market access initiatives for complex therapeutics and medical devices across India, Europe, USA, and Australia.